349 related articles for article (PubMed ID: 31553936)
1. Pharmacological properties and derivatives of shikonin-A review in recent years.
Guo C; He J; Song X; Tan L; Wang M; Jiang P; Li Y; Cao Z; Peng C
Pharmacol Res; 2019 Nov; 149():104463. PubMed ID: 31553936
[TBL] [Abstract][Full Text] [Related]
2. Cellular pharmacology studies of shikonin derivatives.
Chen X; Yang L; Oppenheim JJ; Howard MZ
Phytother Res; 2002 May; 16(3):199-209. PubMed ID: 12164262
[TBL] [Abstract][Full Text] [Related]
3. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.
Zhang X; Cui JH; Meng QQ; Li SS; Zhou W; Xiao S
Mini Rev Med Chem; 2018; 18(2):164-172. PubMed ID: 28245783
[TBL] [Abstract][Full Text] [Related]
4. Shikonin derivatives for cancer prevention and therapy.
Boulos JC; Rahama M; Hegazy MF; Efferth T
Cancer Lett; 2019 Sep; 459():248-267. PubMed ID: 31132429
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of shikonin - a review of literature since 2002.
Andújar I; Ríos JL; Giner RM; Recio MC
Planta Med; 2013 Dec; 79(18):1685-97. PubMed ID: 24155261
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect research progress of shikonin and its derivatives].
Zhu MY; Wang RB; Zhou W; Li SS
Yao Xue Xue Bao; 2012 May; 47(5):588-93. PubMed ID: 22812000
[TBL] [Abstract][Full Text] [Related]
7. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells.
Chang IC; Huang YJ; Chiang TI; Yeh CW; Hsu LS
Biol Pharm Bull; 2010; 33(5):816-24. PubMed ID: 20460760
[TBL] [Abstract][Full Text] [Related]
8. Shikonin and its derivatives: a patent review.
Wang R; Yin R; Zhou W; Xu D; Li S
Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
[TBL] [Abstract][Full Text] [Related]
9. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
10. Traditional chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy.
Andújar I; Recio MC; Giner RM; Ríos JL
Curr Med Chem; 2013; 20(23):2892-8. PubMed ID: 23651309
[TBL] [Abstract][Full Text] [Related]
11. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
Gong K; Li W
Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
[TBL] [Abstract][Full Text] [Related]
12. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice.
Lee HJ; Lee HJ; Magesh V; Nam D; Lee EO; Ahn KS; Jung MH; Ahn KS; Kim DK; Kim JY; Kim SH
Yakugaku Zasshi; 2008 Nov; 128(11):1681-8. PubMed ID: 18981704
[TBL] [Abstract][Full Text] [Related]
13. Shikonin Prevents Early Phase Inflammation Associated with Azoxymethane/Dextran Sulfate Sodium-Induced Colon Cancer and Induces Apoptosis in Human Colon Cancer Cells.
Andújar I; Martí-Rodrigo A; Giner RM; Ríos JL; Recio MC
Planta Med; 2018 Jul; 84(9-10):674-683. PubMed ID: 29642242
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma.
Rajasekar S; Park DJ; Park C; Park S; Park YH; Kim ST; Choi YH; Choi YW
J Ethnopharmacol; 2012 Nov; 144(2):335-45. PubMed ID: 22995444
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological function and evaluation of Shikonin in cancer therapy.
Wang F; Yao X; Zhang Y; Tang J
Fitoterapia; 2019 Apr; 134():329-339. PubMed ID: 30858045
[TBL] [Abstract][Full Text] [Related]
16. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effects of Shikonin on Skin Diseases: A Review.
Mu Z; Guo J; Zhang D; Xu Y; Zhou M; Guo Y; Hou Y; Gao X; Han X; Geng L
Am J Chin Med; 2021; 49(8):1871-1895. PubMed ID: 34961421
[TBL] [Abstract][Full Text] [Related]
18. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor-β1/Smads pathway through shikonin.
Liu T; Xu L; Wang C; Chen K; Xia Y; Li J; Li S; Wu L; Feng J; Xu S; Wang W; Lu X; Fan X; Mo W; Zhou Y; Zhao Y; Guo C
J Gastroenterol Hepatol; 2019 Jan; 34(1):263-276. PubMed ID: 29864192
[TBL] [Abstract][Full Text] [Related]
20. Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.
Li W; Zhang C; Ren A; Li T; Jin R; Li G; Gu X; Shi R; Zhao Y
PLoS One; 2015; 10(5):e0126459. PubMed ID: 25961580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
